{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:06:07Z","timestamp":1758416767088,"version":"3.44.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jns.2015.09.365","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T01:00:03Z","timestamp":1445821203000},"page":"396-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Are PrPCs involved in some human myelin diseases? Relating experimental studies to human pathology"],"prefix":"10.1016","volume":"359","author":[{"given":"Daniela","family":"Veber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scalabrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.09.365_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/bmb\/66.1.43","article-title":"PrP knock-out and PrP transgenic mice in prion research","volume":"66","author":"Weissmann","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jns.2015.09.365_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4161\/pri.1.2.4346","article-title":"The prion protein knockout mouse","volume":"1","author":"Steele","year":"2007","journal-title":"Prion"},{"key":"10.1016\/j.jns.2015.09.365_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","article-title":"The prion\u2019s elusive reason for being","volume":"31","author":"Aguzzi","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2010.01129.x","article-title":"Contribution of transgenic models to understanding human prion disease","volume":"36","author":"Wadsworth","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2015.09.365_bb0025","first-page":"689","article-title":"A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination","volume":"79","author":"Nishida","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jns.2015.09.365_bb0030","first-page":"645","article-title":"Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression","volume":"2007","author":"Nazor","year":"1772","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2015.09.365_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.emboj.7601510","article-title":"Lethal recessive myelin toxicity of prion protein lacking its central domain","volume":"26","author":"Baumann","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.jns.2015.09.365_bb0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.emboj.7601507","article-title":"Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.jns.2015.09.365_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0092-8674(94)90177-5","article-title":"Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins","volume":"76","author":"Westaway","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jns.2015.09.365_bb0055","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1523\/JNEUROSCI.0328-05.2005","article-title":"Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC","volume":"25","author":"Radovanovic","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0060","doi-asserted-by":"crossref","first-page":"e6707","DOI":"10.1371\/journal.pone.0006707","article-title":"Functionally relevant domains of the prion protein identified in vivo","volume":"4","author":"Baumann","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jns.2015.09.365_bb0065","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1523\/JNEUROSCI.0122-04.2004","article-title":"Intrinsic resistance of oligodendrocytes to prion infection","volume":"24","author":"Prinz","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0070","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/sj.emboj.7601726","article-title":"Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.jns.2015.09.365_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1750-3639.2007.00061.x","article-title":"The role of the octarepeat region in neuroprotective function of the cellular prion protein","volume":"17","author":"Mitteregger","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0896-6273(00)00046-5","article-title":"Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice","volume":"27","author":"Flechsig","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2015.09.365_bb0085","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0896-6273(00)80653-4","article-title":"Neurological illness in transgenic mice expressing a prion protein with an insertional mutation","volume":"21","author":"Chiesa","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2015.09.365_bb0090","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1073\/pnas.97.10.5574","article-title":"Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation","volume":"97","author":"Chiesa","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.09.365_bb0095","doi-asserted-by":"crossref","first-page":"10926","DOI":"10.1073\/pnas.88.23.10926","article-title":"Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene","volume":"88","author":"Goldfarb","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.09.365_bb0100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/WNL.46.3.761","article-title":"A prion disease with a novel 96-base pair insertional mutation in the prion protein gene","volume":"46","author":"Campbell","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.09.365_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","article-title":"Prion disease genetics","volume":"14","author":"Mead","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jns.2015.09.365_bb0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.wnl.0000267642.41594.9d","article-title":"Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129","volume":"69","author":"Mead","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.09.365_bb0115","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awr079","article-title":"Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors","volume":"134","author":"Kaski","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-010-9387-0","article-title":"Human prion protein mutants with deleted inserted octarepeats undergo different pathways to trigger cell apoptosis","volume":"43","author":"Xu","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0125","first-page":"629","article-title":"The cellular prion protein (PrPC): its physiological function and role in disease","volume":"2007","author":"Westergard","year":"1772","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2015.09.365_bb0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.00007.2007","article-title":"Physiology of the prion protein","volume":"88","author":"Linden","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jns.2015.09.365_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1139\/o01-142","article-title":"Biology of the prion gene complex","volume":"79","author":"Mastrangelo","year":"2001","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.jns.2015.09.365_bb0140","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1002\/pmic.200600103","article-title":"Identification of proteins with high affinity for refolded and native PrPC","volume":"6","author":"Petrakis","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jns.2015.09.365_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pneurobio.2009.04.004","article-title":"The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency","volume":"88","author":"Scalabrino","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jns.2015.09.365_bb0150","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","article-title":"Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)","volume":"25","author":"Eng","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(94)90480-4","article-title":"Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice","volume":"654","author":"Williams","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0160","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01413-09","article-title":"Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels","volume":"83","author":"Tribouillard-Tanvier","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jns.2015.09.365_bb0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainresrev.2008.05.001","article-title":"Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy","volume":"59","author":"Scalabrino","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jns.2015.09.365_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11940-002-0036-y","article-title":"Peripheral neuropathy due to cobalamin deficiency","volume":"4","author":"Saperstein","year":"2002","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0175","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1096\/fasebj.7.14.7901104","article-title":"Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency","volume":"7","author":"Allen","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2015.09.365_bb0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0950-3536(05)80217-3","article-title":"The biochemical basis of the neuropathy in cobalamin deficiency","volume":"8","author":"Weir","year":"1995","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.jns.2015.09.365_bb0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/exnr.1996.6376","article-title":"Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord","volume":"144","author":"Scalabrino","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.expneurol.2004.12.020","article-title":"Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories","volume":"192","author":"Scalabrino","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molmed.2006.04.008","article-title":"New insights into the pathophysiology of cobalamin deficiency","volume":"12","author":"Scalabrino","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0200","doi-asserted-by":"crossref","first-page":"21930","DOI":"10.1073\/pnas.0811794106","article-title":"Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE","volume":"106","author":"Battaglia-Hsu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.09.365_bb0205","first-page":"250","article-title":"Autonomic nervous system dysfunction and serum levels of neurotoxic and neurotrophic cytokines in patients with cobalamin deficiency","volume":"27","author":"\u00c7eneli","year":"2010","journal-title":"Turk. J. Hematol."},{"key":"10.1016\/j.jns.2015.09.365_bb0210","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3945\/ajcn.110.000802","article-title":"Unexplained chronic cough and vitamin B-12 deficiency","volume":"93","author":"Bucca","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jns.2015.09.365_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003495-199448020-00002","article-title":"The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders","volume":"48","author":"Bottiglieri","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jns.2015.09.365_bb0220","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/0140-6736(91)92373-A","article-title":"Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway","volume":"338","author":"Surtees","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2015.09.365_bb0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj2660707","article-title":"Cobalamin neuropathy. Is S-adenosylhomocysteine toxicity a factor?","volume":"266","author":"Vieira-Makings","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.jns.2015.09.365_bb0230","first-page":"297","article-title":"Subacute combined degeneration and induction of ornithine decarboxylase in spinal cords of totally gastrectomized rats","volume":"62","author":"Scalabrino","year":"1990","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jns.2015.09.365_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2006.04.002","article-title":"Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy","volume":"176","author":"Veber","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2015.09.365_bb0240","series-title":"Prion Biology and Diseases","first-page":"1","article-title":"An introduction to prion biology and diseases","author":"Prusiner","year":"1999"},{"key":"10.1016\/j.jns.2015.09.365_bb0245","series-title":"Norfolk","first-page":"11","article-title":"Function of cellular prion protein","author":"Onodera","year":"2013"},{"key":"10.1016\/j.jns.2015.09.365_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jnr.10118","article-title":"Lack of prion protein expression results in a neuronal phenotype sensitive to stress","volume":"67","author":"Brown","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0255","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/jnr.21599","article-title":"Indirect down-regulation of nuclear NF-\u03baB levels by cobalamin in the spinal cord and liver of the rat","volume":"86","author":"Veber","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0260","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/jvi.68.4.2383-2387.1994","article-title":"Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie","volume":"68","author":"Campbell","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jns.2015.09.365_bb0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2990.2008.00947.x","article-title":"Protein microarray analysis identifies human cellular prion protein interactors","volume":"35","author":"Satoh","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2015.09.365_bb0270","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4049\/jimmunol.1201387","article-title":"Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling","volume":"190","author":"Tsiperson","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2015.09.365_bb0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2011.03.065","article-title":"Akt\/mammalian target of rapamycin signaling pathway regulates neurite out-growth in cerebellar granule neurons stimulated by methylcobalamin","volume":"495","author":"Okada","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.09.365_bb0280","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","article-title":"Neurodegenerative diseases and prions","volume":"344","author":"Prusiner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cmaj.1031155","article-title":"Vitamin B12 (cobalamin) deficiency in elderly patients","volume":"171","author":"Andr\u00e8s","year":"2004","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jns.2015.09.365_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.neuropsych.11020052","article-title":"The neuropsychiatry of vitamin B12 deficiency in elderly patients","volume":"24","author":"Lachner","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jemt.1122","article-title":"Microglia and prion disease","volume":"54","author":"Brown","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jns.2015.09.365_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0173(01)00042-X","article-title":"Microglia and the pathogenesis of spongiform encephalopathies","volume":"35","author":"Rezaie","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jns.2015.09.365_bb0305","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1523\/JNEUROSCI.4303-03.2004","article-title":"Neurons and astrocytes respond to prion infection by inducing microglia recruitment","volume":"24","author":"Marella","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0310","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","article-title":"Prion diseases: from protein to cell pathology","volume":"172","author":"Kovacs","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0315","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jns.2015.09.365_bb0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-010-0735-5","article-title":"Molecular pathology of human prion disease","volume":"121","author":"Wadsworth","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0325","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic analysis of reactive astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0330","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1093\/emboj\/16.20.6057","article-title":"Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie","volume":"16","author":"Raeber","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.jns.2015.09.365_bb0335","first-page":"273","article-title":"Prion diseases","volume":"vol. 2","author":"DeArmond","year":"2002"},{"key":"10.1016\/j.jns.2015.09.365_bb0340","first-page":"1197","article-title":"Prion diseases","volume":"vol. 2","author":"Ironside","year":"2008"},{"key":"10.1016\/j.jns.2015.09.365_bb0345","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0896-6273(95)90307-0","article-title":"Developmental expression of the prion protein gene in glial cells","volume":"14","author":"Moser","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2015.09.365_bb0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005072-199802000-00004","article-title":"Constitutive and cytokine inducible expression of prion protein gene in human neural cell lines","volume":"57","author":"Satoh","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0355","series-title":"Prion Biology and Diseases","first-page":"585","article-title":"Neuropathology of prion diseases","author":"DeArmond","year":"1999"},{"key":"10.1016\/j.jns.2015.09.365_bb0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.biochem.78.082907.145410","article-title":"Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions","volume":"78","author":"Caughey","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jns.2015.09.365_bb0365","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0196-9781(91)90115-6","article-title":"Epidermal growth factor and the nervous system","volume":"12","author":"Plata-Salam\u00e1n","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.jns.2015.09.365_bb0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0082(96)00046-9","article-title":"The neurotrophic action and signalling of epidermal growth factor","volume":"51","author":"Yamada","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jns.2015.09.365_bb0375","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2741\/1210","article-title":"EGF family of growth factors: essential roles and functional redundancy in the nerve system","volume":"9","author":"Xian","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0380","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cytogfr.2004.01.004","article-title":"The role of epidermal growth factor and its receptors in mammalian CNS","volume":"15","author":"Wong","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jns.2015.09.365_bb0385","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0891-5849(03)00360-5","article-title":"Regulation of intrinsic prion protein by growth factors and TNF-\u03b1: the role of intracellular reactive oxygen species","volume":"35","author":"Sauer","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0390","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1006\/bbrc.2000.2152","article-title":"Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines","volume":"268","author":"Kuwahara","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jns.2015.09.365_bb0395","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2006.02.021","article-title":"Regulation of PrPC expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells","volume":"400","author":"Zawlik","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.09.365_bb0400","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.expneurol.2011.11.003","article-title":"Cobalamin (vitamin B12) regulation of PrPC, PrPC-mRNA and copper levels in rat central nervous system","volume":"233","author":"Scalabrino","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0405","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1096\/fasebj.13.2.297","article-title":"Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-\u03b1-mediated","volume":"13","author":"Buccellato","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2015.09.365_bb0410","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnen\/59.9.808","article-title":"Further evidence for the involvement of epidermal growth factor in the signaling pathway of vitamin B12 (cobalamin) in the rat central nervous system","volume":"59","author":"Scalabrino","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0415","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.biocel.2014.09.011","article-title":"Relationships between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system","volume":"55","author":"Scalabrino","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jns.2015.09.365_bb0420","series-title":"The Logic of Scientific Discovery","first-page":"27","author":"Popper","year":"1959"},{"key":"10.1016\/j.jns.2015.09.365_bb0425","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00415-013-7152-3","article-title":"Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis","volume":"261","author":"Scalabrino","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0430","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-510X(98)00005-7","article-title":"Polyneuropathy due to cobalamin deficiency in the rat","volume":"156","author":"Tredici","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.09.365_bb0435","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.22225","article-title":"The octapeptide repeat PrPC region and cobalamin-deficient polyneuropathy of the rat","volume":"44","author":"Scalabrino","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2015.09.365_bb0440","series-title":"Cellular and Molecular Pathogenesis","first-page":"501","article-title":"The Pathobiology of Central Nervous System Degenerative Diseases","author":"VandenBerg","year":"1996"},{"key":"10.1016\/j.jns.2015.09.365_bb0445","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jocn.2012.08.004","article-title":"Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions","volume":"20","author":"Scalabrino","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0450","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.expneurol.2014.07.020","article-title":"Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice","volume":"261","author":"Cristofanilli","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0455","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2015.04.020","article-title":"Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord","volume":"298","author":"Scalabrino","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2015.09.365_bb0460","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2010.03.073","article-title":"Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis","volume":"1333","author":"Scalabrino","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0465","doi-asserted-by":"crossref","first-page":"e33872","DOI":"10.1371\/journal.pone.0033872","article-title":"Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS","volume":"7","author":"Bribi\u00e1n","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.09.365_bb0470","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2353\/ajpath.2008.071062","article-title":"Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis","volume":"173","author":"Tsutsui","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0475","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awp298","article-title":"Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling","volume":"133","author":"Hu","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0480","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-9-25","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system","volume":"9","author":"Gourdain","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2015.09.365_bb0485","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0490","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2005.03.009","article-title":"Vitamin B12, demyelination, remyelination and repair in multiple sclerosis","volume":"233","author":"Miller","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.09.365_bb0495","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0500","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis","volume":"129","author":"DeLuca","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0505","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0510","series-title":"Neuropathology","first-page":"181","article-title":"Dysmyelinating and demyelinating disorders","author":"Kleinschmidt-DeMasters","year":"2005"},{"key":"10.1016\/j.jns.2015.09.365_bb0515","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1098-1136(199812)24:4<382::AID-GLIA3>3.0.CO;2-5","article-title":"Regional potential for oligodendrocyte generation in the rodent embryonic spinal cord following exposure to EGF and FGF-2","volume":"24","author":"Chandran","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.jns.2015.09.365_bb0520","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0962-8924(93)90213-K","article-title":"The oligodendrocyte and its many cellular processes","volume":"3","author":"Pfeiffer","year":"1993","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jns.2015.09.365_bb0525","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jnr.490080233","article-title":"Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system","volume":"8","author":"Simpson","year":"1982","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0530","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00210517","article-title":"Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures","volume":"220","author":"Leutz","year":"1981","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0535","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1523\/JNEUROSCI.17-15-05820.1997","article-title":"Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain","volume":"17","author":"Kuhn","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0540","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/stem.119","article-title":"Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes","volume":"27","author":"Gonzalez-Perez","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.jns.2015.09.365_bb0545","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/glia.20979","article-title":"Dose-dependent effect of EGF on migration and differentiation of adult subventricular zone astrocytes","volume":"58","author":"Gonzalez-Perez","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jns.2015.09.365_bb0550","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1089\/scd.2011.0275","article-title":"Characterization of epidermal growth factor-induced dysplasia in the adult rat subventricular zone","volume":"21","author":"Lindberg","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jns.2015.09.365_bb0555","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.3498986","article-title":"Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor","volume":"238","author":"Morrison","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jns.2015.09.365_bb0560","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jnr.490300306","article-title":"Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: comparison with basic fibroblast growth factor","volume":"30","author":"Ferrari","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0565","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1096\/fasebj.13.14.2083","article-title":"Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B12 (cobalamin) in the rat central nervous system","volume":"13","author":"Scalabrino","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2015.09.365_bb0570","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1523\/JNEUROSCI.16-08-02649.1996","article-title":"In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain","volume":"16","author":"Craig","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0575","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1242\/jcs.048272","article-title":"Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors","volume":"122","author":"Mayer","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jns.2015.09.365_bb0580","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-3806(85)90214-7","article-title":"Epidermal growth factor and bovine growth hormone stimulate differentiation and myelination of brain cell aggregates in culture","volume":"353","author":"Almazan","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0585","first-page":"114","article-title":"Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction","volume":"72","author":"Scalabrino","year":"1995","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jns.2015.09.365_bb0590","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/neu.2009.1209","article-title":"The effect of epidermal growth factor in the injured brain after trauma in rats","volume":"27","author":"Sun","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.jns.2015.09.365_bb0595","doi-asserted-by":"crossref","first-page":"e22623","DOI":"10.1371\/journal.pone.0022623","article-title":"Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming","volume":"6","author":"Gudi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jns.2015.09.365_bb0600","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1073\/pnas.0906589107","article-title":"Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair","volume":"107","author":"Bieber","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.09.365_bb0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00004647-199804000-00002","article-title":"Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries","volume":"18","author":"Peng","year":"1998","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2015.09.365_bb0610","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2004.02.007","article-title":"Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury","volume":"296","author":"Knapp","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0615","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.490300213","article-title":"EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture","volume":"30","author":"Casper","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0620","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0625","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1212\/WNL.41.10.1627","article-title":"Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency","volume":"41","author":"Stabler","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.09.365_bb0630","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ana.20325","article-title":"High tumor necrosis factor-\u03b1 levels in cerebrospinal fluid of cobalamin-deficient patients","volume":"56","author":"Scalabrino","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0635","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2005.11.029","article-title":"Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency","volume":"396","author":"Scalabrino","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.09.365_bb0640","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.02-0231fje","article-title":"Decreased GFAP-mRNA expression in spinal cord of cobalamin-deficient rats","volume":"16","author":"Magnaghi","year":"2002","journal-title":"FASEB J."},{"issue":"Suppl. 69","key":"10.1016\/j.jns.2015.09.365_bb0645","first-page":"1","article-title":"Neurological complications in patients with impaired vitamin B12 absorption following partial gastrectomy","volume":"59","author":"Roos","year":"1978","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2015.09.365_bb0650","series-title":"Cerebrospinal fluid in clinical practice","first-page":"145","article-title":"Nutritional and metabolic disorders","author":"Turtzo","year":"2009"},{"key":"10.1016\/j.jns.2015.09.365_bb0655","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1191\/1352458503ms918oa","article-title":"Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid","volume":"9","author":"Vrethem","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2015.09.365_bb0660","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-\u03b1 and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0665","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/brain\/awf165","article-title":"Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations","volume":"125","author":"Petzold","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0670","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ane.12239","article-title":"Assessing tissue damage in multiple sclerosis: a biomarker approach","volume":"130","author":"Burman","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2015.09.365_bb0675","series-title":"Cerebrospinal fluid in clinical practice","first-page":"209","article-title":"Inflammatory and demyelinating disorders","author":"Cortese","year":"2009"},{"key":"10.1016\/j.jns.2015.09.365_bb0680","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.165.11.6576","article-title":"Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression","volume":"165","author":"Baranzini","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2015.09.365_bb0685","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y","article-title":"Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology","volume":"29","author":"Bitsch","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.jns.2015.09.365_bb0690","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI115102","article-title":"Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions","volume":"87","author":"Selmaj","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2015.09.365_bb0695","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410370115","article-title":"Tumor necrosis factor-\u03b1 messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity","volume":"37","author":"Rieckmann","year":"1995","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2015.09.365_bb0700","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/135245859900500i604","article-title":"Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis","volume":"5","author":"Micera","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2015.09.365_bb0705","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0009-9120(91)90421-A","article-title":"Central nervous system myelin: structure, function, and pathology","volume":"24","author":"Deber","year":"1991","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jns.2015.09.365_bb0710","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jnr.20420","article-title":"Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis","volume":"80","author":"Mastronardi","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2015.09.365_bb0715","first-page":"663","article-title":"The leukodystrophies: overview and classification","volume":"vol. 2","author":"Powers","year":"2004"},{"key":"10.1016\/j.jns.2015.09.365_bb0720","first-page":"165","article-title":"Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study","volume":"30","author":"Tredici","year":"1998","journal-title":"J. Submicrosc. Cytol. Pathol."},{"issue":"Suppl. 35","key":"10.1016\/j.jns.2015.09.365_bb0725","first-page":"8","article-title":"The myelopathy of pernicious anemia. A neuropathological reappraisal","volume":"44","author":"Pant","year":"1968","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2015.09.365_bb0730","unstructured":"Kunze K, Leitenmaier K. Vitamin B12 deficiency and subacute combined degeneration of the spinal cord (Funicular Spinal disease). In: Vinken PJ, Bruyn GW, Klawans HL, editors. Metabolic and deficiency diseases of the nervous system (part II). In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, vol. 28. Amsterdam: Elsevier, 1976:141\u201398"},{"key":"10.1016\/j.jns.2015.09.365_bb0735","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jnen.0000225024.12074.80","article-title":"The pathogenesis of multiple sclerosis: relating human pathology to experimental studies","volume":"65","author":"Ludwin","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0740","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/122.12.2279","article-title":"A quantitative analysis of oligodendrocytes in multiple sclerosis lesions","volume":"122","author":"Lucchinetti","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0745","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/brain\/117.6.1311","article-title":"Patterns of oligodendroglia pathology in multiple sclerosis","volume":"117","author":"Ozawa","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0750","first-page":"1514","article-title":"Demyelinating diseases","volume":"vol. 2","author":"Sobel","year":"2008"},{"key":"10.1016\/j.jns.2015.09.365_bb0755","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.09.365_bb0760","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2015.09.365_bb0765","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1023\/A:1007010205037","article-title":"Axonal pathology in myelin disorders","volume":"28","author":"Bjartmar","year":"1999","journal-title":"J. Neurocytol."},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2015.09.365_bb0770","first-page":"S22","article-title":"Pathogenesis of axonal and neuronal damage in multiple sclerosis","volume":"68","author":"Dutta","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.09.365_bb0775","series-title":"Neuroglia","first-page":"785","article-title":"Multiple sclerosis","author":"Bradl","year":"2013"},{"key":"10.1016\/j.jns.2015.09.365_bb0780","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cne.20102","article-title":"Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis","volume":"473","author":"Nicholas","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0785","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","article-title":"Grey matter pathology in multiple sclerosis","volume":"64","author":"Vercellino","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0790","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2004.09.002","article-title":"The pathology of multiple sclerosis","volume":"23","author":"Lucchinetti","year":"2005","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2015.09.365_bb0795","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1750-3639.2006.00018.x","article-title":"Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology","volume":"16","author":"Gilmore","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0800","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jnnp.2008.148767","article-title":"Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord","volume":"80","author":"Gilmore","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2015.09.365_bb0805","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2015.09.365_bb0810","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0815","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jns.2015.09.365_bb0820","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","article-title":"Cytokines in multiple sclerosis: from bench to bedside","volume":"106","author":"Imitola","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jns.2015.09.365_bb0825","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-015-0515-3","article-title":"Control of autoimmune CNS inflammation by astrocytes","author":"Rothhammer","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jns.2015.09.365_bb0830","first-page":"208","article-title":"Cytokines gene expression in newly diagnosed multiple sclerosis patients","volume":"14","author":"Hasheminia","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.jns.2015.09.365_bb0835","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11481-011-9287-2","article-title":"Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system","volume":"7","author":"Montgomery","year":"2012","journal-title":"J. Neuroimmune Pharmacol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15024533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15024533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:44:12Z","timestamp":1758383052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15024533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":167,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022510X15024533"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.09.365","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are PrPCs involved in some human myelin diseases? Relating experimental studies to human pathology","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.09.365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}